# Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial

> **NCT07697274** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 10 (estimated)

## Conditions studied

- Systemic Sclerosis
- Sclerodactyly

## Interventions

- **DRUG:** Hyaluronidase (Hylenex)

## Key facts

- **NCT ID:** NCT07697274
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-09
- **Final completion:** 2027-11
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697274, "Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*